Weight reduction and weight administration firm WeightWatchers introduced Monday that it’s going to purchase subscription telehealth platform Sequence, permitting the corporate to maneuver into the persistent weight administration area.
The deal is anticipated to shut through the second quarter of 2023, and WeightWatchers pays the web buy value of $106 million.
New York Metropolis-based WeightWatchers is a wellness firm that mixes expertise and group assist to assist folks shed pounds and enhance their health for as much as $43 a month. It incorporates behavioral well being ways, reminiscent of by means of its level monitoring system, that encourage conscious consuming. Sequence, in the meantime, permits sufferers to have digital appointments with a clinician, offers entry to a dietitian and health teaching and supplies prescription drugs, together with Ozempic and Wegovy. The corporate’s providers value $90 a month.
Dr. Gary Foster, chief scientific officer at WeightWatchers, mentioned the corporate continues to be making an attempt to determine how Sequence will match into WeightWatchers’ enterprise and that Sequence will proceed working with its present members and tackle new members. Nonetheless, the acquisition will enable WeightWatchers to maneuver into extra medical care and assist these with persistent weight situations, together with weight problems.
“We all know weight reduction isn’t one dimension matches all,” Foster mentioned in an e mail. “Our present program is the gold normal for behavioral weight reduction and is well-suited for many individuals who need assistance losing a few pounds and protecting it off. Nonetheless, a behavioral program paired with a medical intervention is important to assist folks on persistent weight administration drugs. The acquisition of Sequence will enable for a extra seamless shopper expertise that doesn’t at present exist, integrating the medically suggested behavioral parts, alongside simpler entry for prescription weight reduction drugs, the place deemed acceptable between affected person and clinician.”
Rémi Cossart, CEO and co-founder of Sequence, echoed Foster’s feedback.
“Pairing conduct change with medically acceptable medical options is extra highly effective and extra sustainable than medical alone,” Cossart mentioned. “WeightWatchers is probably the most studied and trusted conduct change program, and their customer-centric strategy to livable, sustainable, science-backed weight administration is unparalleled.”
WeightWatchers, which has been round for about six many years, has about 3.8 million subscribers. Sequence launched in 2021 and has 24,000 members.
The information comes at a time when 41.9% of adults within the U.S. undergo from weight problems and 10.5% of the U.S. inhabitants has diabetes. However medication like Ozempic have elevated in recognition partially as a result of celebrities utilizing the drug for weight reduction, resulting in shortages.
Picture: puhimec, Getty Photographs
